BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

BioPharma Pharma Research

PeptiDream Advances Oral Dual IL17 Inhibitor Into Clinical Development Portfolio

PeptiDream Inc., a public Kanagawa, Japan-based biopharmaceutical company (President: Patrick C. Reid, hereinafter “PeptiDream”)(Tokyo: 4587) a...

December 19, 2025 | News

Colour CT Breakthrough Reaches Europe As Charles University Adopts Advanced MARS Scanner

MARS Bioimaging, a New Zealand–headquartered medical device company specialising in spectral molecular imaging CT scanners that deliver colour 3D X-r...

December 19, 2025 | News

GenSci, RTW And Yarrow Forge US Focused Biotech Partnership To Advance First In Class Thyroid Autoimmune Therapy

Collaboration to focus on building a leading, US-based biotech dedicated to addressing underserved patients impacted by autoimmune and endocrinology di...

December 17, 2025 | News

Pixelgen Expands Asia Pacific Footprint With South Korea Distribution Agreement

- Pixelgen Technologies, Inc. and MDxK (Molecular Diagnostics Korea) Inc., part of DKSH Business Unit Technology, a leader in market expansion se...

December 16, 2025 | News

APAC Biopharma Review 2025: Innovation, Investment, and Influence on the Global Stage

APAC Biopharma in Review: What Truly Moved the Needle This Year Asia-Pacific (APAC) has cemented its status as a pivotal biopharmaceutical hub in 2025, ma...

December 15, 2025 | Report

Sanyou Bio and KanryBio Form Strategic Partnership to Co-Develop Biomarker Assay Kits

Sanyou Biopharmaceuticals (Shanghai) Co., Ltd. ("Sanyou Bio") and Wenzhou KanryBio Biotech Co., Ltd. ("KanryBio") announced a strategi...

December 15, 2025 | News

Zealand Pharma And OTR Therapeutics Forge Strategic Collaboration To Advance Next Generation Metabolic Therapies

Collaboration will combine Zealand Pharma's expertise in obesity and metabolic health with OTR Therapeutics' proprietary oral small-molecule platform and...

December 12, 2025 | News

ProPharma Advances Its India Growth Strategy With Hyderabad Expansion

ProPharma, the leading global provider of regulatory, clinical, and compliance services for the life sciences industry and a portfolio company of Ody...

December 12, 2025 | News

Innovent Doses First Participant in Phase One Trial of Novel IL One RAP Antibody for Gout

Innovent Biologics, Inc. , a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment ...

December 11, 2025 | News

Cytiva And Fida Biosystems Partner To Strengthen Protein Interaction Analysis

Cytiva, a Danaher company and leader in the life sciences industry, and Fida Biosystems, a Danish company specializing in molecular analysis, have joined...

December 10, 2025 | News

South Korea Scientists Introduce MUTE Seq For Ultra Sensitive Cancer Mutation Detection In Liquid Biopsy

MUTE-Seq is a new liquid-biopsy method powered by an engineered ultra-precise CRISPR enzyme, FnCas9-AF2, which can distinguish single-base mismatches acros...

December 10, 2025 | News

Mango Sciences Partners with ImmunoACT to Expand Access to NexCAR19 CAR-T Therapy in India

Mango Sciences, Inc., the Boston, US, and Bengaluru, IN-based data and AI company, announced a strategic partnership with ImmunoAdoptive Cell Therapy (Immu...

December 08, 2025 | News

Neurimmune And Alexion Expand Global Collaboration To Advance NI009 For Light Chain Amyloidosis

Neurimmune announced that it has expanded on its transthyretin amyloid cardiomyopathy (ATTR-CM) collaboration with Alexion, AstraZeneca Rare Disease ...

December 05, 2025 | News

Hiropharmaconsulting Secures Japan Patent For First AI Enabled Pharmacovigilance Validation Method

HiroPharmaConsulting (R) Co., Ltd. announced that it has received a patent for an innovative Good Pharmacovigilance Practice (GVP) Computerized System Vali...

December 05, 2025 | News

Stay Connected